EGFR and lung adenocarcinoma: This study found that in EGFR mutation-positive lung adenocarcinoma patients with pleural invasion, compared with 21-L858R mutation subtypes, patients with low ki-67 expression and family history of tumors were more likely to have 19-del mutations, and patients with 19-del type were more likely to develop pleural thickening.